EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Improvement of Experimentally Induced Gastric Ulcers in Rats by Inhibiting Vascularization Through the Blocking of the TNF‐α Type 1 Receptor

Abdullah Alattar, Reem Alshaman, Fawaz E Alanazi, Omar Bahattab iD, Hanan M Hassan, Mohammed M H Al-Gayyar iD

Immunity, Inflammation and Disease · 2025

DOI: 10.1002/iid3.70279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2025. Verfasst von Abdullah Alattar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia. Hauptthemen laut MEDLINE: Stomach Ulcer, Receptors, Tumor Necrosis Factor, Type I, Neovascularization, Pathologic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

About 5%–10% of the world's population is affected by gastric ulcers, which can result in gastrointestinal perforation and bleeding. Consequently, we aimed to investigate whether blocking TNF‐α type 1 receptor (TNFR1) with CAY10500 could diminish experimentally induced gastric ulcer (GU) in rats by modulating vascularization.

Methods

Rats were administered with a single oral dose of 80 mg/kg of indomethacin to produce gastric ulcers. Subsequently, some rats were given 1 mg/kg of CAY10500 orally. Gastric samples were used to assess the genetic expression and protein levels of TNFR1, VEGF, ERK, PI3K, AKT (also known as PKB), and ICAM‐1. Gastric sections underwent electron microscopic examination and were subjected to hematoxylin and eosin staining and immunostaining using anti‐TNFR1, anti‐VEGF, and anti‐ICAM‐1 antibodies.

Results

CAY10500 demonstrated the ability to inhibit the expression of TNFR1. Examination of micro‐images of GU using electron microscopy or H/E staining revealed extensive necrosis, resulting in the complete loss of regular ultrastructural features of epithelial nuclei and cytoplasmic organelles, as well as the loss of tight junctions and disruption of cell membranes. Significantly, the administration of CAY10500 mitigated these effects. Furthermore, CAY10500 significantly elevated the expressions of VEGF, ERK, PI3K, and AKT, which was associated with a significant reduction in the expression of ICAM‐1.

Conclusion

CAY10500 effectively improved experimentally induced GU in rats. It works by inhibiting TNFR1 and activating angiogenesis and cell proliferation pathways, leading to gastric tissue healing. CAY10500 significantly reduced the adhesion molecule pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach UlcerReceptors, Tumor Necrosis Factor, Type INeovascularization, PathologicAnimalsRatsMaleVascular Endothelial Growth Factor AIntercellular Adhesion Molecule-1Phosphatidylinositol 3-KinasesRats, Sprague-DawleyIndomethacinGastric MucosaDisease Models, AnimalProto-Oncogene Proteins c-aktSignal Transduction

Stichwörter der Autor:innen

extracellular signal‐regulated kinase (ERK)gastric ulcer (GU)intercellular adhesion molecule (ICAM)‐1phosphatidylinositol‐3 kinase (PI3K)protein kinase B (PKB, AKT)tumor necrosis factor‐α type 1 receptor (TNFR1)

Substanzen

Receptors, Tumor Necrosis Factor, Type IVascular Endothelial Growth Factor AIntercellular Adhesion Molecule-1Phosphatidylinositol 3-KinasesIndomethacinProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
  • Department of Biology, Faculty of Science, University of Tabuk, Tabuk, Saudi Arabia.
  • Department of Pharmacology and Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa City, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.

ORCID-Profile: Omar Bahattab, Mohammed M H Al-Gayyar

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Alattar, A., Alshaman, R., Alanazi, F. E., Bahattab, O., Hassan, H. M., & Al-Gayyar, M. M. H. (2025). The Improvement of Experimentally Induced Gastric Ulcers in Rats by Inhibiting Vascularization Through the Blocking of the TNF‐α Type 1 Receptor. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70279

Vancouver

Alattar A, Alshaman R, Alanazi FE, Bahattab O, Hassan HM, Al-Gayyar MMH. The Improvement of Experimentally Induced Gastric Ulcers in Rats by Inhibiting Vascularization Through the Blocking of the TNF‐α Type 1 Receptor. Immunity, Inflammation and Disease. 2025. doi:10.1002/iid3.70279

BibTeX
@article{Alattar2025,
  author = {Alattar, Abdullah and Alshaman, Reem and Alanazi, Fawaz E and Bahattab, Omar and Hassan, Hanan M and Al-Gayyar, Mohammed M H},
  title = {The Improvement of Experimentally Induced Gastric Ulcers in Rats by Inhibiting Vascularization Through the Blocking of the TNF‐α Type 1 Receptor},
  journal = {Immunity, Inflammation and Disease},
  year = {2025},
  doi = {10.1002/iid3.70279}
}
Kostenlos starten →